Biblio Discovery — Demo Discovery Service

1,675 results

Showing 1–20 · 0.13 seconds · RSS

Journal

Therapeutic Advances in Gastroenterology

Scopus

ISSN 1756-283X · SAGE Publishing · 1,675 articles in the index

  1. Journal Article

    A network meta-analysis on the optimal treatment of malignant gastric outlet obstruction

    Takashi Tamura; Ke Wan; Reiko Ashida et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Gastric outlet obstruction (GOO) caused by malignancy significantly impairs patient quality of life. Surgical gastrojejunostomy (SGJ), endoscopic stenting (ES), and endoscopic ultrasound-guided gastroenterostomy (EUS-GE) are the three main palliative treatments. However, the optimal…

  2. Journal Article

    How does survodutide work? Plain language review of a potential new medication for obesity and liver disease

    Jaime P Almandoz; Alexander Dimitri Miras; Jochen Seufert et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Summary What is this review about? This review provides an overview of a medication called survodutide. Survodutide is not yet approved for use but is currently being tested to treat people living with obesity , as well as those living with MASH (metabolic dysfunction–associated steatohepatitis)…

  3. Journal Article

    The potential benefit of sodium glucose cotransporter (SGLT)-2 inhibitors in liver cirrhosis: A mini review

    Michelle Spaan; Abraham S. Meijnikman; Daniel H. van Raalte et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Liver cirrhosis represents a growing global health burden and prognosis is determined by the severity of portal hypertension and the development of complications. Among these, kidney dysfunction stands out as one of the strongest predictors of mortality. Sodium–glucose cotransporter-2 (SGLT2)…

  4. Journal Article

    Subcutaneous infliximab for inflammatory bowel disease: Clinical evidence, pharmacokinetics, and implementation challenges

    Mir Zulqarnain; Parakkal Deepak; Andres J. Yarur

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Infliximab (IFX) has traditionally been administered intravenously (IV) for the treatment of moderate-to-severe ulcerative colitis (UC) and Crohn’s disease (CD). Advances in biologic drug delivery and evolving patient preferences have led to the development of subcutaneous (SC) formulations that…

  5. Journal Article

    Prevalence of non-alcoholic fatty liver disease across populations and comorbid conditions: An umbrella review of meta-analyses

    Yue Feng MD; Peiye Wu MB; Rui Zhao MD, PhD et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Non-alcoholic fatty liver disease (NAFLD) affects approximately one-third of the global population, but reported prevalence varies across populations and comorbid conditions. Objectives To characterize the global prevalence of NAFLD across diverse populations and comorbid conditions…

  6. Journal Article

    Facilitated reintroduction of eliminated eosinophilic esophagitis trigger foods with dupilumab

    Jonathan M. Spergel; Nirmala Gonsalves; Ryan Piansky

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Eosinophilic esophagitis (EoE) is a chronic, type 2 inflammatory disease of the esophagus, characterized by infiltration of eosinophils and symptoms of esophageal dysfunction. EoE is often exacerbated by common trigger foods, such as milk, egg, soy, and wheat, and can be effectively treated by…

  7. Journal Article

    Real-world comparison of second-line infliximab and jak inhibitors for ulcerative colitis after first-line vedolizumab: A comparative multicenter study

    Omer Shohat; Roni Weisshof; Ahinoam Glusman-Bendersky et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Vedolizumab (VDZ) is increasingly used as a first-line biologic therapy for moderate-to-severe ulcerative colitis (UC), but evidence on second-line treatment efficacy following VDZ first-line treatment is lacking. Objectives Real-World Comparison of second-line infliximab and jak…

  8. Journal Article

    The Israeli IBD Research Nucleus: collaborative advancements in Israeli IBD research

    Iris Dotan; Shomron Ben-Horin; Doron Schwartz et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Inflammatory bowel diseases (IBD) are increasing worldwide, requiring multidisciplinary care and coordinated research infrastructures. Leveraging Israel’s integrated healthcare system with IBD centers of specific and complementary research expertise, a national collaborative consortium was…

  9. Journal Article

    From fresh to frozen: evaluating the feasibility of unprocessed raw stool banking for scalable FMT production

    Fedja Farowski; Anastasia Tsakmaklis; Nina Fischer et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Manufacturing of fecal microbiota transplantation (FMT) products from fresh stool donations poses significant logistical, safety, and scalability challenges. Objectives: To evaluate the technical feasibility of freezing unprocessed, raw stool donations prior to manufacturing to improve…

  10. Journal Article

    Elafibranor in selected patients with primary biliary cholangitis and cirrhosis: An exploratory real-world cohort study

    Nargiz Nuruzade; Ulya Oruc; Georgios Konstantis et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Patients with primary biliary cholangitis (PBC) and cirrhosis are a vulnerable population at risk of disease progression and complications. Although elafibranor has shown efficacy in patients with an inadequate response to ursodeoxycholic acid, evidence in individuals with established…

  11. Journal Article

    Acceptability of probiotics, fecal microbiota transplantation, and emerging microbiome-derived therapies in patients with inflammatory bowel diseases: A cross-sectional Survey Study

    Nathan Grellier; Clotilde Policar; Safa Hachicha et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background Microbiome-derived therapies (MDT), including probiotics and fecal microbiota transplantation (FMT), represent promising therapeutic approaches in inflammatory bowel disease (IBD). Objectives We aimed to evaluate patient preferences and determinants of MDT acceptability in IBD. Design…

  12. Journal Article

    Age-stratified colonoscopy outcomes and referral-factor associations in the Swedish colorectal cancer fast-track pathway: a retrospective cohort study

    Abdullah Jajan; Michiel van Nieuwenhoven

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: The standardised course of care colorectal cancer pathway (SCC-CRC) is a symptom-based fast-track diagnostic pathway. Age-related differences in outcomes and referral-factor associations within different age groups are incompletely described. Objective: To describe colonoscopy outcomes…

  13. Journal Article

    The role of enteroscopy in the diagnosis and interventional management of small intestine diseases

    Beata Huszcza; Karolina Grabowska; Tomasz Romańczyk et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Evaluation of the small intestine is technically difficult because of its length and anatomy. Capsule endoscopy and device-assisted enteroscopy (DAE) have expanded diagnostic and therapeutic options in recent years. This narrative review summarizes the current indications, therapeutic procedures…

  14. Journal Article

    Preliminary research on the effectiveness and safety of metal clip-assisted endoscopic variceal ligation in the treatment of gastric varices

    Wang Yi; Li Xiuling; Ding Hui et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Gastric variceal bleeding is a common and serious complication of liver cirrhosis and carries a high mortality. Endoscopic variceal ligation (EVL) is widely used, but its efficacy for gastric varices is limited by incomplete variceal capture and a high rate of post-ligation rebleeding…

  15. Journal Article

    Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experiment: plain language summary of publication

    Daisuke Nakamoto; Yi Piao; Manami Yoshida et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Summary What is this summary about? This summary explains what both people living with hepatitis C and doctors think is meaningful when treating hepatitis C in Japan. We asked people living with hepatitis C and doctors about their opinions on hepatitis C treatment using a questionnaire. What was…

  16. Journal Article

    Robot-assisted versus conventional endoscopic submucosal dissection: a systematic review and meta-analysis

    Menghan Wang; Yan Zhao; Yijun Chen et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Robot-assisted endoscopic submucosal dissection (RA-ESD) has been developed to address the ergonomic and technical limitations of conventional ESD (C-ESD). However, the current evidence base remains limited and is predominantly derived from preclinical studies. Objectives: To…

  17. Journal Article

    Efficacy and safety of risankizumab in moderate-to-severe Crohn’s disease: a systematic review and meta-analysis

    Hafsa Nasim; Abdul Hannan Siddiqui; Syed Jawad Khan et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Crohn’s disease (CD) is a chronic inflammatory disorder with limited therapeutic options for treatment-refractory patients. This meta-analysis evaluates the efficacy and safety of risankizumab (IL-23 p19 inhibitor) in moderate-to-severe CD. Objectives: To evaluate the clinical…

  18. Journal Article

    Impact of wet suction on specimen quality and diagnostic accuracy in EUS-guided tissue acquisition: a systematic review and meta-analysis of randomized controlled trials

    Po-Feng Huang; Jung-Chun Lin; Tien-Yu Huang et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background and aims: Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is critical for diagnosing solid lesions. The wet-suction technique, which pre-fills the needle lumen with saline, has been proposed to improve specimen quality compared with conventional dry suction. This study aimed to…

  19. Journal Article

    Impact of celiac disease on the clinical course of inflammatory bowel disease: CEL_EII study by GETECCU

    Inmaculada Alonso-Abreu; Laura Ramos; Alejandro Hernandez-Camba et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Background: Inflammatory bowel disease (IBD) and celiac disease (CeD) are immune-mediated digestive disorders with shared genetic, immunological, and environmental risk factors. Objectives: This study aimed to assess whether the coexistence of CeD and IBD is associated with a differential IBD…

  20. Journal Article

    International collaborative experiences in managing pyoderma gangrenosum in patients with inflammatory bowel disease

    Jan Guse; Andreas Blesl; Philip Esters et al.

    Therapeutic Advances in Gastroenterology, Vol. 19 · 2026 · English · DOAJ Scopus

    Pyoderma gangrenosum (PG) is a rare but challenging extraintestinal manifestation (EIM) of inflammatory bowel diseases (IBD), affecting 6%–48% of IBD patients. This retrospective study analyzed affected patients and evaluated therapeutic strategies for both IBD remission and PG resolution. A…

Showing at most 50 pages. Narrow your search with filters for more specific results.